113 related articles for article (PubMed ID: 2917019)
21. Immunoconjugate generation between the ribosome inactivating protein restrictocin and an anti-human breast carcinoma MAB.
Orlandi R; Canevari S; Conde FP; Leoni F; Mezzanzanica D; Ripamonti M; Colnaghi MI
Cancer Immunol Immunother; 1988; 26(2):114-20. PubMed ID: 3258791
[TBL] [Abstract][Full Text] [Related]
22. Biochemical and histological characterization of antigens preferentially expressed on the surface and cytoplasm of breast carcinoma cells identified by monoclonal antibodies against the human milk fat globule.
Peterson JA; Zava DT; Duwe AK; Blank EW; Battifora H; Ceriani RL
Hybridoma; 1990 Jun; 9(3):221-35. PubMed ID: 2365381
[TBL] [Abstract][Full Text] [Related]
23. A calicheamicin conjugate with a fully humanized anti-MUC1 antibody shows potent antitumor effects in breast and ovarian tumor xenografts.
Hamann PR; Hinman LM; Beyer CF; Lindh D; Upeslacis J; Shochat D; Mountain A
Bioconjug Chem; 2005; 16(2):354-60. PubMed ID: 15769089
[TBL] [Abstract][Full Text] [Related]
24. Targeted anti-tumor agents and their cytotoxicity on gastric cancer cells in vitro.
Li S; Zhang XY; Chen XT; Fan DM; Tan LS; Pan HZ; Huang LQ
Chin Med J (Engl); 1990 May; 103(5):376-9. PubMed ID: 2118053
[TBL] [Abstract][Full Text] [Related]
25. Modulation of daunorubicin intracellular accumulation in P-glycoprotein expressing MCF-7 human breast adenocarcinoma cells by thermosensitive-liposome encapsulation and hyperthermia.
Merlin JL; Marchal S; Ramacci C; Notter D; Vigneron C
Int J Hyperthermia; 1995; 11(6):855-65. PubMed ID: 8586906
[TBL] [Abstract][Full Text] [Related]
26. In vivo cytotoxicity and antineoplastic activity of a transferrin-daunorubicin conjugate.
Lemieux P; Pagé M; Noël C
In Vivo; 1992; 6(6):621-7. PubMed ID: 1296812
[TBL] [Abstract][Full Text] [Related]
27. In vivo antitumor activity of a monoclonal antibody-Vinca alkaloid immunoconjugate directed against a solid tumor membrane antigen characterized by heterogeneous expression and noninternalization of antibody-antigen complexes.
Starling JJ; Maciak RS; Law KL; Hinson NA; Briggs SL; Laguzza BC; Johnson DA
Cancer Res; 1991 Jun; 51(11):2965-72. PubMed ID: 2032233
[TBL] [Abstract][Full Text] [Related]
28. Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance.
Ross DD; Doyle LA; Yang W; Tong Y; Cornblatt B
Biochem Pharmacol; 1995 Nov; 50(10):1673-83. PubMed ID: 7503771
[TBL] [Abstract][Full Text] [Related]
29. Characterization of a new monoclonal antibody F4 detecting cell surface epitope and P-glycoprotein in drug-resistant human tumor cell lines.
Chu TM; Kawinski E; Lin TH
Hybridoma; 1993 Aug; 12(4):417-29. PubMed ID: 7503940
[TBL] [Abstract][Full Text] [Related]
30. Targeting, internalization, and cytotoxicity of methotrexate-monoclonal anti-stage-specific embryonic antigen-1 antibody conjugates in cultured F-9 teratocarcinoma cells.
Shen WC; Ballou B; Ryser HJ; Hakala TR
Cancer Res; 1986 Aug; 46(8):3912-6. PubMed ID: 2873883
[TBL] [Abstract][Full Text] [Related]
31. The effect of bispecific monoclonal antibody recognizing both hepatoma-specific membrane glycoprotein and anthracycline drugs on the metastatic growth of hepatoma AH66.
Tsukada Y; Ohkawa K; Hibi N; Tsuzuki K; Oguma K; Satoh H
Cancer Biochem Biophys; 1989 May; 10(3):247-56. PubMed ID: 2789098
[TBL] [Abstract][Full Text] [Related]
32. Experimental therapy of human breast tumors with 131I-labeled monoclonal antibodies prepared against the human milk fat globule.
Ceriani RL; Blank EW
Cancer Res; 1988 Aug; 48(16):4664-72. PubMed ID: 3396015
[TBL] [Abstract][Full Text] [Related]
33. The efficacy of WGA modified daunorubicin anti-resistant liposomes in treatment of drug-resistant MCF-7 breast cancer.
Liu S; Song XL; Wang YH; Wang XM; Xiao Y; Wang X; Cheng L; Li XT
J Drug Target; 2017 Jul; 25(6):541-553. PubMed ID: 28277825
[TBL] [Abstract][Full Text] [Related]
34. Antitumor properties of vindesine-monoclonal antibody conjugates.
Rowland GF; Axton CA; Baldwin RW; Brown JP; Corvalan JR; Embleton MJ; Gore VA; Hellström I; Hellström KE; Jacobs E
Cancer Immunol Immunother; 1985; 19(1):1-7. PubMed ID: 3844970
[TBL] [Abstract][Full Text] [Related]
35. Characterization and distribution in human tissues of a glycoproteic antigen defined by monoclonal antibody 1BE12 raised against the human breast cancer cell line T47D.
Pancino G; Charpin C; Osinaga E; Betaille B; Le Roy M; Calvo F; Roseto A
Cancer Res; 1990 Nov; 50(22):7333-42. PubMed ID: 2224861
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibody HMFG-2 retains activity in vivo and binds to high molecular weight components expressed by metastatic breast cancers.
Griffiths AB; Padmanabhan N; Shepherd P; Lazarus C; Maisey M; Fentiman I; Rubens R; Taylor-Papadimitriou J
Mol Biol Med; 1986 Oct; 3(5):425-35. PubMed ID: 3550364
[TBL] [Abstract][Full Text] [Related]
37. Specific cytotoxic effect of neocarzinostatin conjugated to monoclonal antibody A7 on human pancreatic carcinoma.
Otsuji E; Takahashi T; Yamaguchi T; Yamaguchi N; Imanishi J
Gastroenterol Jpn; 1990 Apr; 25(2):244-8. PubMed ID: 2140808
[TBL] [Abstract][Full Text] [Related]
38. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells.
De Vincenzo R; Scambia G; Benedetti Panici P; Fattorossi A; Bonanno G; Ferlini C; Isola G; Pernisco S; Mancuso S
Int J Cancer; 1996 Nov; 68(3):340-8. PubMed ID: 8903476
[TBL] [Abstract][Full Text] [Related]
39. Enhanced expression and secretion of an epithelial membrane antigen (MA5) in a human mucinous breast tumor line (BT549).
Williams CJ; Major PP; Dion AS
Tumour Biol; 1990; 11(3):145-57. PubMed ID: 2160722
[TBL] [Abstract][Full Text] [Related]
40. Engineered thio-trastuzumab-DM1 conjugate with an improved therapeutic index to target human epidermal growth factor receptor 2-positive breast cancer.
Junutula JR; Flagella KM; Graham RA; Parsons KL; Ha E; Raab H; Bhakta S; Nguyen T; Dugger DL; Li G; Mai E; Lewis Phillips GD; Hiraragi H; Fuji RN; Tibbitts J; Vandlen R; Spencer SD; Scheller RH; Polakis P; Sliwkowski MX
Clin Cancer Res; 2010 Oct; 16(19):4769-78. PubMed ID: 20805300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
